MAB858-2
抗-RSV抗体，糖蛋白，所有A、B型毒株，克隆131-2G
clone 131-2G, from mouse
别名:
RSV
登录 查看组织和合同定价。
选择尺寸
关于此项目
UNSPSC Code:
12352203
NACRES:
NA.41
eCl@ss:
32160702
Clone:
131-2G, monoclonal
Species reactivity:
human
Application:
ELISA, IF
Citations:
23
General description
RSV是一种不稳定的副粘病毒，在组织培养中产生人类细胞的特征性融合-合胞体效应。已经鉴定出两种亚型A和B。亚型B的特征是该病毒的无症状株。更严重的临床疾病涉及亚型A株。
Immunogen
A2
表位：某些B型株
Application
ELISA
间接免疫荧光法（新鲜冷冻组织切片）
最终工作稀释度必须由最终用户确定。
间接免疫荧光法（新鲜冷冻组织切片）
最终工作稀释度必须由最终用户确定。
使用经验证可用于ELISA & IF的所有A、B型毒株（克隆131-2G）的抗RSV抗体糖蛋白检测呼吸道合胞病毒。
研究子类别
传染病 - 病毒
传染病 - 病毒
研究类别
传染病
传染病
Biochem/physiol Actions
糖蛋白，89 kD。识别A和B株。
Physical form
形式：纯化
纯化的免疫球蛋白。 1 mg/mL溶于0.02 M PB和0.25 M NaCl（pH=7.6）中，含0.1%叠氮化钠。
Preparation Note
接收之日起，以等分试样在2-8° C下保存长达12个月。 请勿稀释后保存。
Other Notes
浓度：关于批次特定浓度请参见检验报告。
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
除非我们的目录或产品随附的其他公司文件中另有说明，否则我们的产品预期仅用于研究用途，不得用于任何其他目的，包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或对人类或动物的任何类型的消费或应用。
未找到合适的产品？
试试我们的产品选型工具.
存储类别
10 - Combustible liquids
wgk
WGK 2
flash_point_c
Not applicable
Rachel J Derscheid et al.
Viruses, 5(11), 2881-2897 (2013-11-29)
Respiratory syncytial virus (RSV) is the most common cause of bronchiolitis in infants and young children. A small percentage of these individuals develop severe and even fatal disease. To better understand the pathogenesis of severe disease and develop therapies unique
Bo Liang et al.
Journal of virology, 93(7) (2019-01-18)
Human respiratory syncytial virus (RSV) is a major pediatric respiratory pathogen. The attachment (G) and fusion (F) glycoproteins are major neutralization and protective antigens. RSV G is expressed as membrane-anchored (mG) and -secreted (sG) forms, both containing a central fractalkine-like
Caixia Su et al.
NPJ vaccines, 7(1), 168-168 (2022-12-20)
Respiratory syncytial virus (RSV) infection in children is the most common viral respiratory infection and can cause severe lung damage or death. There is no licensed vaccine for preventing RSV infection. Previously we demonstrated that an RSV vaccine, BARS13, consisting
Ana M Nuñez Castrejon et al.
Journal of virology, 96(7), e0220121-e0220121 (2022-03-11)
Respiratory syncytial virus (RSV) is a leading cause of severe lower respiratory tract disease of children, the elderly, and immunocompromised individuals. Currently, there are no FDA-approved RSV vaccines. The RSV G glycoprotein is used for viral attachment to host cells
Myra N Widjojoatmodjo et al.
Virology journal, 7, 114-114 (2010-06-08)
Respiratory syncytial virus (RSV) is a primary cause of serious lower respiratory tract illness for which there is still no safe and effective vaccine available. Using reverse genetics, recombinant (r)RSV and an rRSV lacking the G gene (DeltaG) were constructed
相关内容
MOUSE ANTI-RESPIRATORY SYNCYTIAL VIRUS (RSV
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持